Jun Wen
Impact in
-
- Tuberculosis Research and Epidemiology
-
- Endometriosis Research and Treatment
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Surgery 6
- Lipoproteins and Cardiovascular Health 3
- Helicobacter pylori-related gastroenterology studies 2
- Co-authors
- Xiaoyang Wang (1 shared paper)Jie Ma (1 shared paper)Chun‐Ping Chang (1 shared paper)Wei Feng (1 shared paper)Maikel Petrus Peppelenbosch (1 shared paper)Jun Qing Yu (1 shared paper)Harry Cheuk-Hay Lau (1 shared paper)Yaping Li (1 shared paper)
- Journals
- Frontiers in Microbiology (1 paper)Diabetology & Metabolic Syndrome (1 paper)JAAD International (1 paper)Frontiers in Pediatrics (1 paper)Energy Economics (1 paper)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Jun Wen
23 papers receiving 314 citations
Peers
Comparison fields: 5 of 72
- Infectious Diseases 40
- Reproductive Medicine 20
- Economics and Econometrics 51
- Clinical Biochemistry 8
- Marketing 14
Countries citing papers authored by Jun Wen
This map shows the geographic impact of Jun Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Wen more than expected).
Fields of papers citing papers by Jun Wen
This network shows the impact of papers produced by Jun Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Wen. The network helps show where Jun Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 75 | |
| 2 | 2005 | 38 | |
| 3 | Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis. | 2006 | 35 |
| 4 | 2012 | 25 | |
| 5 | 2023 | 23 | |
| 6 | 2021 | 22 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 16 | |
| 9 | 2019 | 10 | |
| 10 | 2024 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2023 | 7 | |
| 13 | Kappa-opioid receptor stimulation contributes to aortic artery dilation through activation of K(ATP) channel in the rats. | 2003 | 6 |
| 14 | 2023 | 6 | |
| 15 | 2024 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 3 |
About Jun Wen
Jun Wen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Hepatology, Pharmacology and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 323 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipoproteins and Cardiovascular Health (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Liver Disease and Transplantation (2 papers), Tuberculosis Research and Epidemiology (2 papers), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Underwater Vehicles and Communication Systems (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Infectious Diseases (40 citations), Reproductive Medicine (20 citations), Economics and Econometrics (51 citations), Clinical Biochemistry (8 citations) and Marketing (14 citations). Jun Wen has collaborated with scholars based in China, France and United States. Frequent co-authors include Xiaoyang Wang, Jie Ma, Chun‐Ping Chang, Wei Feng, Maikel Petrus Peppelenbosch, Jun Qing Yu, Harry Cheuk-Hay Lau, Yaping Li, Xin Sun and Chunli Shao. Their work appears in journals such as Frontiers in Microbiology, Diabetology & Metabolic Syndrome, JAAD International, Frontiers in Pediatrics and Energy Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.